Deduction of Novel Genes Potentially Involved in the Effects of Very Low Dose Atropine (0.003%) Treatment on Corneal Epithelial Cells Using Next-Generation Sequencing and Bioinformatics Approaches

Background and Objectives: Atropine is a nonselective muscarinic antagonist which has been used to prevent worsening of myopia in children. Different concentrations of atropine were used for myopia, ranging from 0.01% to 1.0%. However, there are still potential toxicity of different doses of atropin...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Wei-An, Hsiao, Yu-Ting, Lin, Hsien-Chung, Jian, Shu-Fang, Chen, Yi-Jen, Kuo, Po-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780702/
https://www.ncbi.nlm.nih.gov/pubmed/31540331
http://dx.doi.org/10.3390/medicina55090589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780702/
https://www.ncbi.nlm.nih.gov/pubmed/31540331
http://dx.doi.org/10.3390/medicina55090589

Ejemplares similares